Article
An inhibitor of glucosylceramide synthase inhibits the human enzyme, but not enzymes from other organisms.
Bioscience, biotechnology, and biochemistry - 1 Sept 2005
Hillig Inga, Warnecke Dirk, Heinz Ernst
Abstract excerpt
Specific inhibitors of glucosylceramide biosynthesis are used as drugs for the treatment of some human diseases correlated to glycosphingolipid metabolism. The target of the presently available inhibitors is the human glucosylceramide synthase (GCS), but effects on enzymes from other organisms have not been studied. We expressed cDNAs encoding GCS enzymes from lower animals, plants, fungi, and bacteria in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
